Anatomy and Pathophysiology of the Prostate Gland
The origin of the term “prostate” was originally derived from the Greek prohistani (to stand in front of) and has been attributed to Herophilus of Alexandria, who used the expression in 335 B.C. to describe the organ located “in front of” the urinary bladder. However, while the existence of the prostate has been recognised for over 2300 years, the gland’s anatomy, physiology and pathology has been described in detail only within the past six decades. Recently there has been a flurry of interest and activity in relation to the three major prostatic diseases: benign prostatic hyperplasia (BPH), carcinoma of the prostate and prostatitis. This is partly because demographic changes have led to an ever-increasing proportion of men attaining an age at which they are especially susceptible to these disorders, and because of the introduction of new therapies for these diseases. Central to the understanding of both benign and malignant prostatic pathology is comprehension of the zonal anatomy. This chapter relates differences in zonal anatomy to the various pathological processes which frequently affect this gland.
Unable to display preview. Download preview PDF.
- Bostnick DG (1987) Introductal dysplasia: a premaliquand condition of the prostate. Hum Pathol 17:64–71Google Scholar
- Gleason DF (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea and Febiger, Philadelphia, pp 171–198Google Scholar
- Humphrey PA (1991) Mutin in severe dysplasia in the prostate. Surg Pathol 4:137–143Google Scholar
- Miller GJ (1988) An atlas of prostatic biopsies: dilemmas of morphologic variance. In: Fenoglio-Preiser CM, Wolff M, Rilke F (eds) Progress in surgical pathology VIII. Field and Wood, Philadelphia, pp 81–112Google Scholar
- Oesterling JE, Brendler CB, Epstein JI, Kimball AW Jr, Walsh PC (1987) Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138:92–98PubMedGoogle Scholar